LEO III Fund acquires PronoKal Group from Nestlé Health Science to drive Innovation an global growth in ketogenic Nutrition
Munich/Barcelona, Juli 31, 2025 – We’re proud to announce that LEO III Fund has successfully acquired PronoKal Group from Nestlé Health Science.
With this acquisition, PronoKal will now operate as an independent company – ready to strengthen its leading position in the fast-growing ketogenic nutrition market.
Backed by a strong foundation in science-based, medically supervised nutrition, the company is ideally positioned to accelerate innovation, expand internationally, and deliver sustainable health solutions with real impact.
This transaction reflects DUBAG Group’s ongoing commitment to unlocking value in complex corporate carve-outs and supporting long-term, purpose-driven growth.
A big thank-you to Nestlé Health Science for the trustful collaboration and to everyone who contributed to the success of this transaction, especially our DUBAG deal team for their dedication and tireless efforts:
Deal Team: Dr. Michael Schumann, Emanuel Cattanei, Sebastian Stalter & Fabian Hilke
Legal: Sven Schweneke & Daniel Mursa (Taylor Wessing) & Emilio Prieto (Ecija)